Dr. Cassady is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
555 S 18th St
Columbus, OH 43205Phone+1 614-722-6200Fax+1 614-722-4565
Education & Training
- University of WashingtonResidency, Pediatrics, 1991 - 1994
- University of Alabama School of MedicineClass of 1991
Certifications & Licensure
- ID State Medical License 1993 - Present
- OR State Medical License 1994 - Present
- OH State Medical License 2015 - 2025
- AL State Medical License 1995 - 2015
- WA State Medical License 1991 - 1995
- American Board of Pediatrics Pediatric Infectious Diseases
Publications & Presentations
PubMed
- 157 citationsInosine is an alternative carbon source for CD8+-T-cell function under glucose restrictionTingting Wang, JN Rashida Gnanaprakasam, Xuyong Chen, Siwen Kang, Xuequn Xu
Nature Metabolism. 2020-06-15 - 26 citationsProduction of bioactive soluble interleukin-15 in complex with interleukin-15 receptor alpha from a conditionally-replicating oncolytic HSV-1.David C. Gaston, Carl I. Odom, Li Li, James M. Markert, Justin C. Roth
Plos One. 2013-11-27 - 24 citationsCombination Therapy Using Ruxolitinib and Oncolytic HSV Renders Resistant MPNSTs Susceptible to VirotherapyMohammed G. Ghonime, Kevin A. Cassady
Cancer Immunology Research. 2018-10-23
Press Mentions
- Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022March 9th, 2022
- Mustang Bio Announces City of Hope, University of Alabama at Birmingham and Nationwide Children’s Hospital Abstract Accepted for Late-Breaker Poster Presentation at the American Association for Cancer Research (AACR) Annual Meeting 2022March 9th, 2022
- Study Supports Virotherapy as a Potential Treatment for Brain TumorsFebruary 1st, 2022
- Join now to see all
Grant Support
- HSV US11 Mediated Evasion Of Host ShutoffNational Institute Of Allergy And Infectious Diseases2000–2001
- HSV-1 US11 Mediated Evasion Of Host ShutoffNational Institute Of Allergy And Infectious Diseases1999
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: